xmlui.ArtifactBrowser.ItemViewer.show_simple
Homeopathic medicines for prevention of influenza and acute respiratory tract infections in children: blind, randomized, placebo-controlled clinical trial
| dc.contributor.author | Siqueira, Camila Monteiro | |
| dc.contributor.author | Homsani, Fortune | |
| dc.contributor.author | Veiga, Venício Féo da | |
| dc.contributor.author | Lyrio, Carlos | |
| dc.contributor.author | Mattos, Haroldo José de | |
| dc.contributor.author | Passos, Sonia Regina Lambert | |
| dc.contributor.author | Couceiro, José Nelson | |
| dc.contributor.author | Quaresma, Carla Holandino | |
| dc.date.accessioned | 2017-02-14T11:27:47Z | |
| dc.date.available | 2017-02-14T11:27:47Z | |
| dc.date.issued | 2016 | |
| dc.identifier.citation | SIQUEIRA, Camila Monteiro et al. Homeopathic medicines for prevention of influenza and acute respiratory tract infections in children: blind, randomized, placebo-controlled clinical trial. Homeopathy, v. 105, n. 1, p. 71-77, 2016. | en_US |
| dc.identifier.issn | 1476-4245 | |
| dc.identifier.uri | http://dspace.iec.gov.br/handle/iec/2513 | |
| dc.description.sponsorship | FAPERJ; Instituto Roberto Costa; (CAPES) | pt_BR |
| dc.language.iso | eng | en_US |
| dc.publisher | Elsevier | pt_BR |
| dc.rights | Acesso Restrito | pt_BR |
| dc.title | Homeopathic medicines for prevention of influenza and acute respiratory tract infections in children: blind, randomized, placebo-controlled clinical trial | en_US |
| dc.type | Artigo | pt_BR |
| dc.date.iso | 20170214 | |
| dc.subject.decsPrimary | Influenza Humana | pt_BR |
| dc.subject.decsPrimary | Vacinas contra Influenza | pt_BR |
| dc.subject.decsPrimary | Medicamento Homeopático | pt_BR |
| dc.subject.decsPrimary | Homeopatia | pt_BR |
| dc.subject.decsPrimary | Ensaio Clínico | pt_BR |
| dc.subject.decsPrimary | Sistema Único de Saúde | pt_BR |
| dc.subject.decsPrimary | Petrópolis (RJ) | pt_BR |
| dc.creator.affilliation | Universidade Federal do Rio de Janeiro. Faculdade de Farmácia. Departamento de Medicamentos. Rio de Janeiro, RJ, Brazil / Instituto Federal do Rio de Janeiro. Rio de Janeiro, RJ, Brazil. | pt_BR |
| dc.creator.affilliation | Universidade Federal do Rio de Janeiro. Faculdade de Farmácia. Departamento de Medicamentos. Rio de Janeiro, RJ, Brazil. | pt_BR |
| dc.creator.affilliation | Universidade Federal do Rio de Janeiro. Instituto de Microbiologia Professor Paulo de Góes. Rio de Janeiro, RJ, Brazil. | pt_BR |
| dc.creator.affilliation | Instituto Roberto Costa. Rio de Janeiro, RJ, Brazil. | pt_BR |
| dc.creator.affilliation | Ministério da Saúde. Secretaria de Vigilância em Saúde. Instituto Evandro Chagas. Ananindeua, PA, Brazil. | pt_BR |
| dc.creator.affilliation | Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brazil. | pt_BR |
| dc.creator.affilliation | Universidade Federal do Rio de Janeiro. Instituto de Microbiologia Professor Paulo de Góes. Rio de Janeiro, RJ, Brazil. | pt_BR |
| dc.creator.affilliation | Universidade Federal do Rio de Janeiro. Faculdade de Farmácia. Departamento de Medicamentos. Rio de Janeiro, RJ, Brazil. | pt_BR |
| dc.description.abstracten | Background: Influenza and its complications are common at all ages, especially in children. Vaccines and anti-influenza drugs aim to prevent it. Preventative approaches with favorable risk profiles should be considered for flu, particularly since the evidence of the efficacy of anti-viral drugs is debated. Methods: This pragmatic clinical trial was conducted in the Brazilian Public Health System in Petrópolis (BPHSP) with children aged from 1 to 5 years old. The medications used were mainly selected based on in vitro experiments (InfluBio), and in successful qualitative clinical experiences (Homeopathic Complex). Following informed parental consent, subjects were randomly distributed, in a blind manner, to three experimental groups: Homeopathic Complex, Placebo, and InfluBio. BPHSP health agents collected flu and acute respiratory infection symptomatic episodes monthly following the established protocol. The number of these episodes was registered in one year (2009–2010). Results: Out of the 600 children recruited, 445 (74.17%) completed the study (149: Homeopathic complex; 151: Placebo; 145: InfluBio). The number of flu and acute respiratory infection symptomatic episodes detected in this clinical trial was low; however, it was different between homeopathic groups and placebo (p < 0.001). In the first year post-intervention, 46/151 (30.5%) of children in the placebo group developed 3 or more flu and acute respiratory infection episodes, while there was no episode in the group of 149 children who used Homeopathic Complex, and only 1 episode in the group of 145 (1%) children who received InfluBio. Conclusion: These results suggested that the use of homeopathic medicines minimized the number of flu and acute respiratory infection symptomatic episodes in children, signalizing that the homeopathic prophylactic potential should be investigated in further studies. | en_US |
| dc.identifier.doi | 10.1016/j.homp.2015.02.006 |
